Latest filing published 06 Jul 2022 for AVITA Medical, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Erin Liberto: trading record in brief
All filings by Erin Liberto on record concern AVITA Medical, Inc., in the capacity of senior executive. In total, 2 filings cover trades dated from 6 July 2021 to 1 July 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 6 July 2022: a share grant, in AVITA Medical, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erin Liberto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,950 sharesCommon StockSEC:0001209191-22-041377:0
- 10,500 sharesCommon StockSEC:0001209191-21-054953:0
2 of 2 declarations
